Your browser doesn't support javascript.
loading
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature.
Kelkka, Tiina; Savola, Paula; Bhattacharya, Dipabarna; Huuhtanen, Jani; Lönnberg, Tapio; Kankainen, Matti; Paalanen, Kirsi; Tyster, Mikko; Lepistö, Maija; Ellonen, Pekka; Smolander, Johannes; Eldfors, Samuli; Yadav, Bhagwan; Khan, Sofia; Koivuniemi, Riitta; Sjöwall, Christopher; Elo, Laura L; Lähdesmäki, Harri; Maeda, Yuka; Nishikawa, Hiroyoshi; Leirisalo-Repo, Marjatta; Sokka-Isler, Tuulikki; Mustjoki, Satu.
Afiliação
  • Kelkka T; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Savola P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Bhattacharya D; Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Huuhtanen J; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Lönnberg T; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Kankainen M; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Paalanen K; Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Tyster M; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Lepistö M; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Ellonen P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Smolander J; Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Eldfors S; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Yadav B; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Khan S; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Koivuniemi R; Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Sjöwall C; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Lähdesmäki H; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Maeda Y; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Nishikawa H; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Leirisalo-Repo M; Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.
  • Sokka-Isler T; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Mustjoki S; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Front Immunol ; 12: 710831, 2021.
Article em En | MEDLINE | ID: mdl-34135915
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2020.578848.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia